Koichi Yasuda1
Naomi Kiyota2*
Kazuto Matsuura3
Satoshi Saito4
Yoshitaka Honma5
Yoshinori Imamura6
Kaoru Tanaka7
Sadamoto Zenda8
Takuma Onoe9
Takeshi Kodaira10
Satoshi Kobayashi11Hidefumi Aoyama12
Nobuhiro Hanai13
Akihiro Homma14 on behalf of Head Neck Cancer Study Group of Japan Clinical Oncology Group (JCOG)- 1Department of Radiation Oncology, Hokkaido University Hospital, Sapporo, Japan
- 2Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Japan
- 3Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan
- 4Department of Radiation Oncology, Saitama Medical University International Medical Center, Hidaka, Japan
- 5Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
- 6Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
- 7Department of Medical Oncology, Kindai University Faculty of Medicine, OsakaSayama, Japan
- 8Department of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan
- 9Division of Medical Oncology, Hyogo Cancer Center, Akashi, Japan
- 10Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, Japan
- 11Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan
- 12Department of Radiation Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
- 13Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
- 14Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
by Yasuda K, Kiyota N, Matsuura K, Saito S, Honma Y, Imamura Y, Tanaka K, Zenda S, Onoe T, Kodaira T, Kobayashi S, Aoyama H, Hanai N and Homma A (2025). Front. Oncol. 14:1441056. doi: 10.3389/fonc.2024.1441056
In the published article, Supplementary Materials 1 and 2 were mistakenly not included in the publication. The missing material appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: older patients, head and neck cancer, chemoradiotherapy, radiotherapy, cisplatin
Citation: Yasuda K, Kiyota N, Matsuura K, Saito S, Honma Y, Imamura Y, Tanaka K, Zenda S, Onoe T, Kodaira T, Kobayashi S, Aoyama H, Hanai N and Homma A (2025) Corrigendum: Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group. Front. Oncol. 15:1558600. doi: 10.3389/fonc.2025.1558600
Received: 10 January 2025; Accepted: 27 March 2025;
Published: 10 April 2025.
Edited and Reviewed by:
Petr Szturz, Centre Hospitalier Universitaire Vaudois (CHUV), SwitzerlandCopyright © 2025 Yasuda, Kiyota, Matsuura, Saito, Honma, Imamura, Tanaka, Zenda, Onoe, Kodaira, Kobayashi, Aoyama, Hanai and Homma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Naomi Kiyota, bmtpeW90YUBtZWQua29iZS11LmFjLmpw